Skip to content
GLP-1 Decoder

Victoza Pen: Strengths, Generic Pens

Victoza pen: which forms exist, which are FDA approved, and how they differ.

Active ingredient
liraglutide
Manufacturer
Novo Nordisk
How it is taken
Daily injection
FDA-approved for
Type 2 diabetes, Heart risk
Victoza pen: GLP-1 medicines as a pen, a pill and a vial

Victoza in brief

How long it stays in your body
100%50%25%0%013 h26 h39 h2.2 d2.7 d50%25%12.5%time after the dose

Its half-life is about 13 hours: after 13 h half is gone, and after five half-lives (2.7 d) about 3% is left.

The weight lost in its main trial
Victoza (LEAD-3)2.5 kgPlacebo1.1 kg

In LEAD-3, people with type 2 diabetes lost 2.5 kg over 52 weeks, versus 1.1 kg for placebo.

Sources: FDA label (DailyMed).